LMNA and cardiomyopathy: Improvement of the clinical symptoms and the left ventricle ejection fraction was observed after proper treatment.<h4>Conclusions</h4>This case report suggests for the first time a potential genetic predisposition for anthracyclines induced cardiomyopathy in patients with mutations in LMNA gene.